Carotid Stenosis and Stroke: Medicines, Stents, Surgery—“Wait-and-See” or Protect?

Piotr Musialek; Kenneth Rosenfield; Adnan H. Siddiqui; Iris Q. Grunwald

doi:10.1055/a-1952-1159

Thrombosis and Haemostasis, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Thromb Haemost 2024; 124(09): 815-827
DOI: 10.1055/a-1952-1159

Invited Mini Series

Carotid Stenosis and Stroke: Medicines, Stents, Surgery—“Wait-and-See” or Protect?

Authors

Piotr Musialek

¹Department of Cardiac and Vascular Diseases, Jagiellonian University, Krakow, Poland

²John Paul II Hospital Stroke Thrombectomy-Capable Centre, Krakow, Poland
Kenneth Rosenfield

³Division of Cardiology, Vascular Medicine and Intervention Section, Massachusetts General Hospital, Boston, United States
Adnan H. Siddiqui

⁴Departments of Neurosurgery and Radiology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, United States

⁵Jacobs Institute, Buffalo, New York, United States

⁶Department of Neurosurgery, Gates Vascular Institute Kaleida Health, Buffalo, New York, United States
Iris Q. Grunwald

⁷Department of Radiology, Ninewells Hospital, Chair of Neuroradiology, University of Dundee, Dundee, Scotland, United Kingdom

Abstract

Volltext

Referenzen

References
1 Pearson J, Sipido KR, Musialek P, van Gilst WH. The Cardiovascular Research community calls for action to address the growing burden of cardiovascular disease. Cardiovasc Res 2019; 115 (10) e96-e98
2 Mozaffarian D, Benjamin EJ, Go AS. et al; Writing Group Members, American Heart Association Statistics Committee, Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2016; 133 (04) e38-e360
3 Adamson J, Beswick A, Ebrahim S. Is stroke the most common cause of disability?. J Stroke Cerebrovasc Dis 2004; 13 (04) 171-177
4 Sturm JW, Donnan GA, Dewey HM. et al. Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2004; 35 (10) 2340-2345
5 Musiałek P, Grunwald IQ. How asymptomatic is “asymptomatic” carotid stenosis? Resolving fundamental confusion(s) - and confusions yet to be resolved. Pol Arch Intern Med 2017; 127 (11) 718-719
6 Hackam DG, Kapral MK, Wang JT, Fang J, Hachinski V. Most stroke patients do not get a warning: a population-based cohort study. Neurology 2009; 73 (13) 1074-1076
7 Paraskevas KI, Eckstein HH, Mikhailidis DP, Veith FJ, Spence JD. Rationale for screening selected patients for asymptomatic carotid artery stenosis. Curr Med Res Opin 2020; 36 (03) 361-365
8 Musialek P, Hopf-Jensen S. Carotid artery revascularization for stroke prevention: a new era. J Endovasc Ther 2017; 24 (01) 138-148
9 Wafa HA, Wolfe CDA, Emmett E, Roth GA, Johnson CO, Wang Y. Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years. Stroke 2020; 51 (08) 2418-2427
10 Spagnoli LG, Mauriello A, Sangiorgi G. et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004; 292 (15) 1845-1852
11 Sakakura K, Nakano M, Otsuka F, Ladich E, Kolodgie FD, Virmani R. Pathophysiology of atherosclerosis plaque progression. Heart Lung Circ 2013; 22 (06) 399-411
12 Powers WJ, Rabinstein AA, Ackerson T. et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2019; 50 (12) e344-e418
13 Ni H, Zhou C, Hang Y. et al. Endovascular treatment for acute ischaemic stroke caused by isolated internal carotid artery occlusion: treatment strategies, outcomes, and prognostic factors. Clin Radiol 2023; 78 (06) 451-458
14 Yeo LLL, Kong WY, Paliwal P. et al. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion. J Stroke Cerebrovasc Dis 2016; 25 (10) 2423-2429
15 Saqqur M, Uchino K, Demchuk AM. et al; CLOTBUST Investigators. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38 (03) 948-954
16 Bhatia R, Hill MD, Shobha N. et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010; 41 (10) 2254-2258
17 Koga M, Arihiro S, Miyashita F. et al. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke. Cerebrovasc Dis 2013; 36 (04) 299-305
18 Rubiera M, Ribo M, Delgado-Mederos R. et al. Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis. Stroke 2006; 37 (09) 2301-2305
19 Podlasek A, Grunwald IQ, Musiałek P. The evolution from an “average” study patient to patient-specific characteristics to guide interventions in vascular medicine. Pol Arch Intern Med 2021; 131 (01) 5-8
20 Musialek P, Bonati LH, Bulbulia R. et al. Stroke risk management in carotid atherosclerotic disease: A Clinical Consensus Statement of the ESC Council on Stroke and the ESC Working Group on Aorta and Peripheral Vascular Diseases. Cardiovasc Res 2023; (e-pub ahead of print)
21 Larson A, Nardi V, Brinjikji W, Benson JC, Lanzino G, Savastano L. Endarterectomy for symptomatic non-stenotic carotids: a systematic review and descriptive analysis. Stroke Vasc Neurol 2022; 7 (01) 6-12
22 Abbott AL, Bladin CF, Levi CR, Chambers BR. What should we do with asymptomatic carotid stenosis?. Int J Stroke 2007; 2 (01) 27-39
23 Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009; 40 (10) e573-e583
24 Mizowaki T, Fujita A, Inoue S. et al. Outcome and effect of endovascular treatment in stroke associated with acute extracranial internal carotid artery occlusion: Single-center experience in Japan. J Stroke Cerebrovasc Dis 2020; 29 (07) 104824
25 Ospel JM, Marko M, Singh N, Goyal M, Almekhlafi MA. Prevalence of Non-Stenotic (<50%) Carotid Plaques in Acute Ischemic Stroke and Transient Ischemic Attack: A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis 2020; 29 (10) 105117
26 Kopczak A, Schindler A, Bayer-Karpinska A. et al. Complicated Carotid Artery Plaques as a Cause of Cryptogenic Stroke. J Am Coll Cardiol 2020; 76 (19) 2212-2222
27 Kamtchum-Tatuene J, Wilman A, Saqqur M, Shuaib A, Jickling GC. Carotid Plaque With High-Risk Features in Embolic Stroke of Undetermined Source: Systematic Review and Meta-Analysis. Stroke 2020; 51 (01) 311-314
28 Kopczak A, Schindler A, Sepp D. et al. Complicated Carotid Artery Plaques and Risk of Recurrent Ischemic Stroke or TIA. J Am Coll Cardiol 2022; 79 (22) 2189-2199
29 Tekieli L, Mazurek A, Dzierwa K. et al. Misclassification of carotid stenosis severity with area stenosis-based evaluation by computed tomography angiography: impact on erroneous indication to revascularization or patient (lesion) migration to a higher guideline recommendation class as per ESC/ESVS/ESO/SVS and CMS-FDA thresholds. Adv Interv Cardiol 2022; 18 (04) 500-513
30 Tekieli L, Kablak-Ziembicka A, Dabrowski W. et al. Imaging modality-dependent carotid stenosis severity variations against intravascular ultrasound as a reference: Carotid Artery intravasculaR Ultrasound Study (CARUS). Int J Cardiovasc Imaging 2023; 39 (10) 1909-1920
31 de Weerd M, Greving JP, de Jong AW, Buskens E, Bots ML. Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis. Stroke 2009; 40 (04) 1105-1113
32 Petrova M, Kiat H, Gavino A, McLachlan CS. Carotid ultrasound screening programs in rural communities: a systematic review. J Pers Med 2021; 11 (09) 897
33 Porcu M, Mannelli L, Melis M. et al. Carotid plaque imaging profiling in subjects with risk factors (diabetes and hypertension). Cardiovasc Diagn Ther 2020; 10 (04) 1005-1018
34 Redgrave JN, Lovett JK, Syed AB, Rothwell PM. Histological features of symptomatic carotid plaques in patients with impaired glucose tolerance and diabetes (oxford plaque study). Cerebrovasc Dis 2008; 26 (01) 79-86
35 Sarwar N, Gao P, Seshasai SR. et al; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375 (9733): 2215-2222
36 Wei LM, Zhu YQ, Bao YQ. et al. Atherosclerosis in intracranial or extracranial vessels in diabetic patients and the association with stroke subtype. Quant Imaging Med Surg 2019; 9 (06) 960-967
37 Mazurek A, Borratynska A, Gancarczyk U. et al. Diabetes Mellitus and Clinical Outcomes in Carotid Artery Revascularization Using Second-Generation, MicroNet-Covered Stents: Analysis from the PARADIGM Study. J Diabetes Res 2022; 2022: 8691842
38 Conrad MF, Michalczyk MJ, Opalacz A, Patel VI, LaMuraglia GM, Cambria RP. The natural history of asymptomatic severe carotid artery stenosis. J Vasc Surg 2014; 60 (05) 1218-1226
39 Paraskevas KI, Nicolaides AN, Kakkos SK. Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) study: what have we learned from it?. Ann Transl Med 2020; 8 (19) 1271
40 Conrad MF, Boulom V, Mukhopadhyay S, Garg A, Patel VI, Cambria RP. Progression of asymptomatic carotid stenosis despite optimal medical therapy. J Vasc Surg 2013; 58 (01) 128-35.e1
41 Vanassche T, Lauw MN, Eikelboom JW. et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J 2015; 36 (05) 281-7a
42 Högberg D, Björck M, Mani K, Svensjö S, Wanhainen A. Five year outcomes in men screened for carotid artery stenosis at 65 years of age: a population based cohort study. Eur J Vasc Endovasc Surg 2019; 57 (06) 759-766
43 Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med 2011; 364 (18) 1746-1760
44 Ząbczyk M, Natorska J, Undas A. Fibrin clot properties in atherosclerotic vascular disease: from pathophysiology to clinical outcomes. J Clin Med 2021; 10 (13) 2999
45 Loeffen R, Spronk HM, ten Cate H. The impact of blood coagulability on atherosclerosis and cardiovascular disease. J Thromb Haemost 2012; 10 (07) 1207-1216
46 Ząbczyk M, Ariëns RAS, Undas A. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice. Cardiovasc Res 2023; 119 (01) 94-111
47 Musiałek P, Monteiro A, Siddiqui AH. Atrial fibrillation and stroke: more than a story of a villain and a victim. Pol Arch Intern Med 2022; 132 (02) 16213
48 Khan AA, Patel J, Desikan S. et al. Asymptomatic carotid artery stenosis is associated with cerebral hypoperfusion. J Vasc Surg 2021; 73 (05) 1611-1621.e2
49 Grunwald IQ, Papanagiotou P, Reith W. et al. Influence of carotid artery stenting on cognitive function. Neuroradiology 2010; 52 (01) 61-66
50 Antonopoulos CN, Kakisis JD, Sfyroeras GS. et al. The impact of carotid artery stenting on cognitive function in patients with extracranial carotid artery stenosis. Ann Vasc Surg 2015; 29 (03) 457-469
51 Gaba K, Bulbulia R. Identifying asymptomatic patients at high-risk for stroke. J Cardiovasc Surg (Torino) 2019; 60 (03) 332-344
52 Banerjee C, Moon YP, Paik MC. et al. Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study. Stroke 2012; 43 (05) 1212-1217
53 Paraskevas KI, Mikhailidis DP, Veith FJ, Spence JD. Definition of best medical treatment in asymptomatic and symptomatic carotid artery stenosis. Angiology 2016; 67 (05) 411-419
54 Paraskevas KI, Mikhailidis DP, Baradaran H. et al. Optimal management of asymptomatic carotid stenosis: counterbalancing the benefits with the potential risks. J Stroke 2022; 24 (01) 163-165
55 Ding WY, Rivera-Caravaca JM, Marin F, Torp-Pedersen C, Roldán V, Lip GYH. Prediction of residual stroke risk in anticoagulated patients with atrial fibrillation: mCARS. J Clin Med 2021; 10 (15) 335
56 Paraskevas KI, Veith FJ, Ricco JB. Best medical treatment alone may not be adequate for all patients with asymptomatic carotid artery stenosis. J Vasc Surg 2018; 68 (02) 572-575
57 Musialek P, Mazurek A, Trystula M. et al. Novel PARADIGM in carotid revascularisation: Prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuard™ MicroNet-covered embolic prevention stent system. EuroIntervention 2016; 12 (05) e658-e670
58 Stabile E, de Donato G, Musialek P. et al. Use of dual-layered stents for carotid artery angioplasty: 1-year results of a patient-based meta-analysis. JACC Cardiovasc Interv 2020; 13 (14) 1709-1715
59 Aboyans V, Ricco JB, Bartelink MEL. et al; ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018; 39 (09) 763-816
60 Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312 (7023): 71-72
61 Ding WY, Rivera-Caravaca JM, Marín F, Li G, Roldán V, Lip GYH. Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidence. Br J Clin Pharmacol 2022; 88 (01) 282-289
62 Brott TG, Halperin JL, Abbara S. et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. Catheter Cardiovasc Interv 2013; 81 (01) E76-E123
63 Kamtchum-Tatuene J, Noubiap JJ, Wilman AH, Saqqur M, Shuaib A, Jickling GC. Prevalence of high-risk plaques and risk of stroke in patients with asymptomatic carotid stenosis: a meta-analysis. JAMA Neurol 2020; 77 (12) 1524-1535
64 Nakagawa I, Kotsugi M, Park HS. et al. Near-infrared spectroscopy carotid plaque characteristics and cerebral embolism in carotid artery stenting. EuroIntervention 2021; 17 (07) 599-606
65 Musialek P, Dabrowski W, Mazurek A. et al. Quantitative virtual histology for in vivo evaluation of human atherosclerosis—a plaque biomechanics-based novel image analysis algorithm: validation and applications to atherosclerosis research. In: Balocco S. ed. Intravascular Ultrasound: From Acquisition to Advanced Quantitative Analysis. New York, NY: Elsevier; 2020: 71-96
66 Liapis CD, Eckstein HH, Paraskevas KI, Cronenwett JL. Emerging evidence suggests that patients with high-grade asymptomatic carotid stenosis should be revascularized. J Vasc Surg 2022; 75 (1S): 23S-25S
67 Hosseini AA, Simpson RJ, Altaf N, Bath PM, MacSweeney ST, Auer DP. Magnetic resonance imaging plaque hemorrhage for risk stratification in carotid artery disease with moderate risk under current medical therapy. Stroke 2017; 48 (03) 678-685
68 Musialek P, Tracz W, Tekieli L. et al. Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis. J Clin Neurol 2013; 9 (03) 165-175
69 Zhang Y, Bai Y, Xie J. et al. Carotid plaque components and other carotid artery features associated with risk of stroke: A systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2022; 31 (12) 106857
70 Högberg D, Mani K, Wanhainen A, Svensjö S. Clinical effect and cost-effectiveness of screening for asymptomatic carotid stenosis: a Markov model. Eur J Vasc Endovasc Surg 2018; 55 (06) 819-827
71 Poorthuis MHF, Sherliker P, de Borst GJ. et al. Detection rates of asymptomatic carotid artery stenosis and atrial fibrillation by selective screening of patients without cardiovascular disease. Int J Cardiol 2023; 391: 131262
72 Khaleghi M, Isseh IN, Jouni H, Sohn S, Bailey KR, Kullo IJ. Family history as a risk factor for carotid artery stenosis. Stroke 2014; 45 (08) 2252-2256
73 Sangiorgi G, Bedogni F, Sganzerla P. et al. The Virtual histology In CaroTids Observational RegistrY (VICTORY) study: a European prospective registry to assess the feasibility and safety of intravascular ultrasound and virtual histology during carotid interventions. Int J Cardiol 2013; 168 (03) 2089-2093
74 Kotsugi M, Takayama K, Myouchin K. et al. Carotid artery stenting: investigation of plaque protrusion incidence and prognosis. JACC Cardiovasc Interv 2017; 10 (08) 824-831
75 Musialek P, Capoccia L, Alvarez CA. et al. Carotid Artery Endovascular Reconstruction Using Micronet-Covered Stents in Patients with Symptoms or Signs of Cerebral Ischemia (CGuard OPTIMA Trial Investigators; OPtimal sequestration of high-risk carotid lesions with effecTive lumen reconstruction usIng MicroNet–covered stents And the endovascular route, NCT04234854). TCT Featured Research. Available from: https://d18mqtxkrsjgmh.cloudfront.net/public/2022-09/a355a7ab-6d71-44de-8ecf-6712bd763300.pdf [accessed 12 November2023].
76 Obeid T, Arnaoutakis DJ, Arhuidese I. et al. Poststent ballooning is associated with increased periprocedural stroke and death rate in carotid artery stenting. J Vasc Surg 2015; 62 (03) 616-23.e1
77 Musiałek P, Roubin GS. Double-layer carotid stents: from the clinical need, through a stent-in-stent strategy, to effective plaque isolation… the journey toward safe carotid revascularization using the endovascular route. J Endovasc Ther 2019; 26 (04) 572-577
78 Karpenko A, Bugurov S, Ignatenko P. et al. Randomized controlled trial of conventional versus MicroNet-covered stent in carotid artery revascularization. JACC Cardiovasc Interv 2021; 14 (21) 2377-2387
79 Traenka C, Engelter ST, Brown MM, Dobson J, Frost C, Bonati LH. Silent brain infarcts on diffusion-weighted imaging after carotid revascularisation: A surrogate outcome measure for procedural stroke? A systematic review and meta-analysis. Eur Stroke J 2019; 4 (02) 127-143
80 Gensicke H, Zumbrunn T, Jongen LM. et al; ICSS-MRI Substudy Investigators. Characteristics of ischemic brain lesions after stenting or endarterectomy for symptomatic carotid artery stenosis: results from the international carotid stenting study-magnetic resonance imaging substudy. Stroke 2013; 44 (01) 80-86
81 Musiałek P, Hopkins LN, Siddiqui AH. One swallow does not a summer make but many swallows do: accumulating clinical evidence for nearly-eliminated peri-procedural and 30-day complications with mesh-covered stents transforms the carotid revascularisation field. Adv Interv Cardiol 2017; 13 (02) 95-106
82 Karpenko A, Bugurov S, Ignatenko P. et al. Randomized Controlled Trial of Conventional Versus MicroNet-Covered Stent in Carotid Artery Revascularization: 12-Month Outcomes. JACC Cardiovasc Interv 2023; 16 (07) 878-880
83 Musialek P, Langhoff R, Stefanini M, Gray WA. Carotid stent as cerebral protector: the arrival of Godot. J Cardiovasc Surg (Torino) 2023; 64 (06) 555-560
84 Mauriello A, Servadei F, Sangiorgi G. et al. Asymptomatic carotid plaque rupture with unexpected thrombosis over a non-canonical vulnerable lesion. Atherosclerosis 2011; 218 (02) 356-362
85 de Donato G, Setacci F, Sirignano P, Galzerano G, Cappelli A, Setacci C. Optical coherence tomography after carotid stenting: rate of stent malapposition, plaque prolapse and fibrous cap rupture according to stent design. Eur J Vasc Endovasc Surg 2013; 45 (06) 579-587
86 Okazaki T, Sakamoto S, Shinagawa K. et al. Detection of in-stent protrusion (ISP) by intravascular ultrasound during carotid stenting: Usefulness of stent-in-stent placement for ISP. Eur Radiol 2019; 29 (01) 77-84
87 Musialek P, de Donato G. Carotid artery revascularization using the endovascular route. In: Peripheral Interventions–Practical Guide. Turin: Edizioni Minerva Medica; 2023: 142-72
88 Sardar P, Chatterjee S, Aronow HD. et al. Carotid artery stenting versus endarterectomy for stroke prevention: a meta-analysis of clinical trials. J Am Coll Cardiol 2017; 69 (18) 2266-2275
89 Brott TG, Calvet D, Howard G. et al; Carotid Stenosis Trialists' Collaboration. Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data. Lancet Neurol 2019; 18 (04) 348-356
90 Rosenfield K, Matsumura JS, Chaturvedi S. et al; ACT I Investigators. ACT I Investigators. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med 2016; 374 (11) 1011-1020
91 Halliday A, Bulbulia R, Bonati LH. et al; ACST-2 Collaborative Group. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet 2021; 398 (10305): 1065-1073
92 Mazurek A, Malinowski K, Rosenfield K. et al. CARMEN (CArotid Revascularization Systematic Reviews and MEta-aNalyses) Investigators. Clinical Outcomes of Second-versus First-Generation Carotid Stents: A Systematic Review and Meta-Analysis. J Clin Med 2022; 11: 4819
93 Metzger DC. (on behalf of CGUARDIANS FDA-IDE Trial Investigators). 30-Day Results From the C-Guardians Pivotal Trial of the CGuard™ Carotid Stent System. Available from: https://vivafoundation.org/news-article?id = 17808 [accessed 12 November 2023]
94 Mazurek A, Malinowski K, Sirignano P. et al; CArotid Revascularization systematic reviews and MEta-aNalyses (CARMEN) Collaborators. Carotid artery revascularization using second generation stents versus surgery: a meta-analysis of clinical outcomes. J Cardiovasc Surg (Torino) 2023; 64 (06) 570-582
95 Halliday A, Harrison M, Hayter E. et al; Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 2010; 376 (9746): 1074-1084
96 Machalińska A, Kowalska-Budek A, Kawa MP. et al. Effect of carotid endarterectomy on retinal function in asymptomatic patients with hemodynamically significant carotid artery stenosis. Pol Arch Intern Med 2017; 127 (11) 722-729
97 Trystuła M, Musiałek P. Transient flow reversal combined with sustained embolic prevention in transcervical revascularization of symptomatic and highly-emboligenic carotid stenoses for optimized endovascular lumen reconstruction and improved peri- and post-procedural outcomes. Adv Interv Cardiol 2020; 16 (04) 495-506
98 Kumins NH, King AH, Ambani RN. et al. Anatomic criteria in the selection of treatment modality for atherosclerotic carotid artery disease. J Vasc Surg 2020; 72 (04) 1395-1404
99 Galyfos GC, Tsoutsas I, Konstantopoulos T. et al. Early and late outcomes after transcarotid revascularisation for internal carotid artery stenosis: a systematic review and metaanalysis. Eur J Vasc Endovasc Surg 2021; 61 (05) 725-738
100 Leckie K, Tanaka A, Dakour-Aridi H. et al. Predictors of 30-Day Stroke and Death After Transcarotid Revascularization. J Surg Res 2023; 283: 146-151
101 Trystula M, Van Herzele I, Kolvenbach R. et al. Next-generation transcarotid artery revascularization: transcarotid flOw reversal cerebral protection and CGUARD MicroNET-Covered embolic prevention stent system to reduce strokes – TOPGUARD Study. J Cardiovasc Surg 2024;65 [in press]
102 Sharma M, Hart RG, Connolly SJ. et al. Stroke outcomes in the COMPASS trial. Circulation 2019; 139 (09) 1134-1145
103 Schwartz GG, Szarek M, Bittner VA. et al; ODYSSEY Outcomes Committees and Investigators. Lipoprotein(a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol. J Am Coll Cardiol 2021; 78 (05) 421-433
104 Siudut J, Ząbczyk M, Wołkow P, Polak M, Undas A, Jawień J. Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: Association with lipoproteins and C-reactive protein. Vascul Pharmacol 2022; 144: 106977
105 Paszek E, Pociask E, Ząbczyk M. et al. Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients. Atherosclerosis 2022; 346: 124-132
106 Stabile E, de Donato G, Musialek P. et al. Use of Dual-Layered Stents in Endovascular Treatment of Extracranial Stenosis of the Internal Carotid Artery: Results of a Patient-Based Meta-Analysis of 4 Clinical Studies. JACC Cardiovasc Interv 2018; 11 (23) 2405-2411
107 Mazurek A, Borratynska A, Malinowski KP. et al. MicroNET-covered stents for embolic prevention in patients undergoing carotid revascularisation: twelve-month outcomes from the PARADIGM study. EuroIntervention 2020; 16 (11) e950-e952
108 Dzierwa K, Kedziora A, Tekieli L. et al. Endovascular carotid revascularization under open-chest extracorporeal circulation combined with cardiac surgery in unstable patients at increased risk of carotid-related stroke: SIMultaneous urgent cardiac surgery and MicroNet-covered stent carotid revascularization in extreme-risk patients-SIMGUARD Study. J Cardiovasc Surg (Torino) 2023; 64 (06) 591-607
109 Mazurek A, Partyka L, Trystula M. et al. Highly-calcific carotid lesions endovascular management in symptomatic and increased-stroke-risk asymptomatic patients using the CGuard™ dual-layer carotid stent system: Analysis from the PARADIGM study. Catheter Cardiovasc Interv 2019; 94 (01) 149-156
110 Eckstein HH, Reiff T, Ringleb P, Jansen O, Mansmann U, Hacke W. et al; SPACE 2 Investigators. SPACE-2: a missed opportunity to compare carotid endarterectomy, carotid stenting, and best medical treatment in patients with asymptomatic carotid stenoses. Eur J Vasc Endovasc Surg 2016; 51 (06) 761-765
111 Musiałek P. TASTE-less endpoint of 30-day mortality (and some other issues with TASTE) in evaluating the effectiveness of thrombus aspiration in STEMI: not the “evidence” to change the current practice of routine consideration of manual thrombus extraction. Kardiol Pol 2014; 72 (06) 479-487
112 Dzierwa K, Capoccia L, Knapik M. et al. Saving the brain in carotid-related stroke: patient pathways, treatment strategies. J Cardiovasc Surg 2024 [in press]
113 Gaba K, Ringleb PA, Halliday A. Asymptomatic carotid stenosis: intervention or best medical therapy?. Curr Neurol Neurosci Rep 2018; 18 (11) 80
114 Aro E, Ijäs P, Vikatmaa L. et al. The efficacy of carotid surgery by subgroups: the concept of stroke prevention potential. Eur J Vasc Endovasc Surg 2019; 58 (01) 5-12
115 Cohen DJ, Stolker JM, Wang K. et al; CREST Investigators. Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol 2011; 58 (15) 1557-1565
116 Trystuła M, Tomaszewski T, Pąchalska M. Health-related quality of life in ischaemic stroke survivors after carotid endarterectomy (CEA) and carotid artery stenting (CAS): confounder-controlled analysis. Adv Interv Cardiol 2019; 15 (02) 226-233
117 Cleveland TJ, Gaines PA, Venables GS. Carotid artery stenosis. Patients should have access to all treatments. BMJ 2010; 340: c1467
118 Högberg D, Björck M. Response to “Re. Five year outcomes in men screened for carotid artery stenosis at 65 years of age: a population based cohort study”. Eur J Vasc Endovasc Surg 2020; 59 (01) 152